Results for this period
First quarter2025年7月1日〜2025年9月30日ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
症例増加及び新規顧客獲得等に伴う販売拡大により手術室関連製品等の販売が好調に推移した。人員採用・ベースアップ等による人件費、物流コスト、貸倒引当金繰入額は増加したが、増収効果で利益が増加した。
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年7月1日〜2025年9月30日 |
| Net Sales | ¥72,168 million (YoY +4.4%) |
| Operating profit | ¥158 million (YoY +3.2%) |
| Ordinary income | ¥269 million (YoY +11.1%) |
| Profit attributable to owners of the parent | ¥108 million (YoY +47.1%) |
| Net income per share | ¥4.88 |
| Equity ratio | End of the current fiscal period 17.1 / End of previous period 18.1 |
| Total assets | ¥117,473 million |
| Net assets | ¥20,072 million |
| Full-year earnings forecast | Net Sales ¥305,000 million (YoY +5.6%) / Operating profit ¥1,750 million (YoY -6.7%) / Ordinary income ¥2,300 million (YoY -5.1%) / Net income ¥1,300 million (YoY -5.5%) |
| Annual Dividend Forecast | ¥20 → ¥20(0.0%) |
| Segment revenue | Medical Equipment Sales Business ¥70,753.41 thousand (YoY +4.5%), Nursing Care and Welfare Business ¥1,415.04 thousand (YoY -3.5%) |
| Segment profit | Medical Equipment Sales Business ¥2,383.16 thousand (YoY +6.0%), Nursing Care and Welfare Business ¥116.35 thousand (YoY +11.7%) |
| Depreciation and amortization | ¥452,301 thousand |
| Impairment loss | ¥3,801 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥1,046 thousand, Gain on sale of investment securities ¥66 thousand / Extraordinary loss Loss on disposal of property, plant and equipment ¥251 thousand, Impairment loss ¥3,801 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社レップス / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Held No / Subject person Not disclosed |
| Issued Shares at Period-End | 22,238,217 shares |
| Treasury Shares at Period-End | 958 shares |
| Factors Behind Changes in Business Performance | 症例増加及び新規顧客獲得等に伴う販売拡大により手術室関連製品等の販売が好調に推移した。人員採用・ベースアップ等による人件費、物流コスト、貸倒引当金繰入額は増加したが、増収効果で利益が増加した。 |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.症例増加及び新規顧客獲得等に伴う販売拡大により手術室関連製品等の販売が好調に推移したため。人員採用・ベースアップによる人件費、物流コスト、取引先の倒産による貸倒引当金繰入額などは増加したが、増収効果により各利益が増加した。